Clinical and Parasite Species Risk Factors for Pentavalent Antimonial Treatment Failure in Cutaneous Leishmaniasis in Peru-Reference-Cited by-同舟云学术

Clinical and Parasite Species Risk Factors for Pentavalent Antimonial Treatment Failure in Cutaneous Leishmaniasis in Peru

Published:2008-01-15 Issue:2 Volume:46 Page:223-231
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Llanos-Cuentas A.,Tulliano G.,Araujo-Castillo R.,Miranda-Verastegui C.,Santamaria-Castrellon G.,Ramirez L.,Lazo M.,De Doncker S.,Boelaert M.,Robays J.,Dujardin J.-C.,Arevalo J.,Chappuis F.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/46/2/223/1241654/46-2-223.pdf

Reference60 articles.

1. The increase in risk factors for leishmaniasis worldwide

2. IMPACT OF ILLNESS AND NON-COMBAT INJURY DURING OPERATIONS IRAQI FREEDOM AND ENDURING FREEDOM (AFGHANISTAN)

3. Old World Leishmaniasis: An Emerging Infection among Deployed US Military and Civilian Workers

4. Conflict and Kala‐Azar: Determinants of Adverse Outcomes of Kala‐Azar among Patients in Southern Sudan

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of topical rSm29 in combination with intravenous meglumine antimoniate in the treatment of cutaneous leishmaniasis: A randomized controlled trial;International Journal of Infectious Diseases;2024-10

2. Natural resistance to meglumine antimoniate is associated with treatment failure in cutaneous leishmaniasis caused by Leishmania (Viannia) panamensis;PLOS Neglected Tropical Diseases;2024-05-06

3. Sampling is decisive to determination of Leishmania (Viannia) species;PLOS Neglected Tropical Diseases;2024-04-25

4. In Situ versus Systemic Immune Response in the Pathogenesis of Cutaneous Leishmaniasis;Pathogens;2024-02-23

5. Consolidation of a Molecular Signature of Healing in Cutaneous Leishmaniasis Is Achieved during the First 10 Days of Treatment;The Journal of Immunology;2024-01-17